| Serial Number | 79284012 |
| Word Mark | TRB |
| Filing Date | Wednesday, March 11, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 2, 2021 |
| Registration Number | 6258760 |
| Registration Date | Tuesday, February 2, 2021 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 17, 2020 |
| Indication of Colors claimed | The color(s) blue is/are claimed as a feature of the mark. |
| Description of Mark | The mark consists of a circular design outlined in blue containing zig-zag bands in blue followed to the right by the letters "TRB" in blue. The color white represents background, outlining, shading, and/or transparent areas and is not part of the mark. |
| Goods and Services | pharmaceuticals, namely, anti-neurodegenerative, anti-neurotrophic, anti-antineurotoxic, neuroprotective and neurorestorative effect agents; pharmaceuticals, namely, immunopharmaceuticals; medical and veterinary preparations, namely, preparations for use in treating joint disease in horses, and antioxidants; pharmaceutical and medicinal preparations and substances for treating and preventing ophthalmic, ocular, neurological, metabolic, dermatological, arthritic, cognitive, or sexual dysfunction-related conditions, disorders or diseases; pharmaceutical and medicinal preparations and substances for treating and preventing joint, ligament, tendon, cartilage, bone, damaged skin or tissue-related conditions, disorders or diseases; pharmaceutical and medicinal preparations and substances for the treatment of central or peripheral nervous system-related, spinal cord-related, or early stages of traumatic or acute vascular injury-related disorders and diseases; pharmaceutical and medicinal preparations and substances for the treatment of pain, inflammation, physical lesions, and wounds; analgesics; anti-inflammatories; medicines for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; medicines for use as surgical aid during cataract surgery procedures; medicines for the treatment of osteoarthritis and rheumatoid arthritis; medicines for the prevention of osteoporosis; medicines for the treatment of musculo-skeletal conditions, disorders or diseases; medicines for the treatment of tendinopathy; medicines for joint recovery after arthroscopy; medicines to help assist with the regeneration of ligament and tendon fibers; medicines for the treatment of immune system related diseases and disorders; medicines for the treatment of blepharitis, glaucoma, and degenerative eye pathologies; pharmaceutical drugs for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; pharmaceutical drugs for use as surgical aid during cataract surgery procedures; pharmaceutical drugs for the treatment of osteoarthritis and rheumatoid arthritis; pharmaceutical drugs for the prevention of osteoporosis; pharmaceutical drugs for the treatment of musculo-skeletal conditions, disorders or diseases; pharmaceutical drugs for the treatment of tendinopathy; pharmaceutical drugs for joint recovery after arthroscopy; pharmaceutical drugs to help assist with the regeneration of ligament and tendon fibers; pharmaceutical drugs for the treatment of immune system related diseases and disorders; pharmaceutical drugs for the treatment of blepharitis, glaucoma, and degenerative eye pathologies; therapeutic drugs for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; therapeutic drugs for use as surgical aid during cataract surgery procedures; therapeutic drugs for the treatment of osteoarthritis and rheumatoid arthritis; therapeutic drugs for the prevention of osteoporosis; therapeutic drugs for the treatment of musculo-skeletal conditions, disorders or diseases; therapeutic drugs for the treatment of tendinopathy; therapeutic drugs for joint recovery after arthroscopy; therapeutic drugs to help assist with the regeneration of ligament and tendon fibers; therapeutic drugs for the treatment of immune system related diseases and disorders, and therapeutic agents for the treatment of keratitis, Sjögren's syndrome or primary dry eye syndrome; therapeutic agents for use as surgical aid during cataract surgery procedures; therapeutic agents for the treatment of osteoarthritis and rheumatoid arthritis; therapeutic agents for the prevention of osteoporosis; therapeutic agents for the treatment of musculo-skeletal conditions, disorders or diseases; therapeutic agents for the treatment of tendinopathy; therapeutic agents for joint recovery after arthroscopy; therapeutic agents to help assist with the regeneration of ligament and tendon fibers; therapeutic agents for the treatment of immune system related diseases and disorders; transdermal patches featuring vitamins for increasing energy for medical use; biological cartilage, bone or skin tissue intended for subsequent implantation; biological preparations for medical or veterinary use, namely, for the treatment of infectious diseases; sanitary preparations for medical purposes; dietetic food and substances in the nature of food supplements and vitamins supplements all adapted for medical or veterinary use; food for babies; dietary supplements for humans and animals; meal replacements, namely, meal replacement bars adapted for medical use and meal replacement beverages adapted for medical use, and dietetic beverages adapted for medical and veterinary use; materials for dressings, namely, dressings for wounds, burns or surgery, adhesive bandages, gauze for dressings, pledgets; disinfectants |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 27, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TRB CHEMEDICA INTERNATIONAL SA |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | CH |
| Party Name | TRB CHEMEDICA INTERNATIONAL SA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | CH |
| Party Name | TRB CHEMEDICA INTERNATIONAL SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 33 - NOT AVAILABLE |
| Address | CH |
| Event Date | Event Description |
| Thursday, April 23, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, April 27, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 1, 2020 | APPLICATION FILING RECEIPT MAILED |
| Thursday, May 21, 2020 | ASSIGNED TO EXAMINER |
| Thursday, May 28, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, May 29, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, June 30, 2020 | REFUSAL PROCESSED BY MPU |
| Tuesday, June 30, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, July 18, 2020 | REFUSAL PROCESSED BY IB |
| Wednesday, October 7, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 7, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 8, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 13, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 28, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 17, 2020 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 17, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 2, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Sunday, May 2, 2021 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, May 5, 2021 | FINAL DISPOSITION PROCESSED |
| Wednesday, May 5, 2021 | FINAL DISPOSITION NOTICE SENT TO IB |
| Tuesday, May 18, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, May 18, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, May 18, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sunday, May 30, 2021 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Sunday, February 26, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sunday, February 26, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Sunday, February 26, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sunday, June 9, 2024 | CHANGE OF NAME/ADDRESS REC'D FROM IB |
| Sunday, June 30, 2024 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Wednesday, September 18, 2024 | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED |
| Wednesday, November 26, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, November 26, 2025 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |